Fed. Circ. Won't Block Generic Lung Drug During Appeal
The Federal Circuit has refused to block Sandoz from launching a generic version of pulmonary fibrosis drug Esbriet, rejecting Genentech's bid for an injunction during an appeal in litigation involving the...To view the full article, register now.
Already a subscriber? Click here to view full article